Pharma: Other News To Note
Merck Serono SA, of Geneva, said it is taking its first step into the biosimilar space through a partnership with Dr. Reddy's Laboratories Ltd., of Hyderabad, India. The partnership will focus on co-developing a portfolio of biosimilar cancer compounds, most of which will be monoclonal antibodies. The agreement, based on full R&D cost-sharing, covers co-development, manufacturing and commercialization of the compounds.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-877-857-2477
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter